The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Abstract
Diabetic nephropathy is characterized by excessive amassing of extracellular matrix (ECM) with thickening of glomerular and tubular basement membranes and increased amount of mesangial matrix, which ultimately progress to glomerulosclerosis and tubulo-interstitial fibrosis. In view of this outcome, it would mean that all the kidney cellular elements, i.e., glomerular endothelia, mesangial cells, podocytes, and tubular epithelia, are targets of hyperglycemic injury. Conceivably, high glucose activates various pathways via similar mechanisms in different cell types of the kidney except for minor exceptions that are related to the selective expression of a given molecule in a particular renal compartment. To begin with, there is an obligatory excessive channeling of glucose intermediaries into various metabolic pathways with generation of advanced glycation products (AGEs), activation of protein kinase C (PKC), increased expression of transforming growth factor-β (TGF-β), GTP-binding proteins, and generation of reactive oxygen species (ROS). The ROS seem to be the common denominator in various pathways and are central to the pathogenesis of hyperglycemic injury. In addition, there are marked alterations in intraglomerular hemodynamics, i.e., hyperfiltration, and this along with metabolic derangements adversely compounds the hyperglycemia-induced injury. Here, the information compiled under various subtitles of this article is derived from an enormous amount of data summarized in several excellent literature reviews, and thus their further reading is suggested to gain in-depth knowledge of each of the subject matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lin, S., Sahai, A., Chugh, S. S., Pan, X., Wallner, E. I., Danesh, F. R., Lomasney, J. W., & Kanwar, Y. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203957200 · Cited by 50
Self-citationRetractedBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Hostetter, T. H., Rennke, H. G., & Brenner, B. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90490-9 · Cited by 796
Extracellular Matrix Metabolism in Diabetic Nephropathy
Mason, R. M., & Wahab, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065640.77499.d7 · Cited by 655
Contribution of Polyol Pathway to Diabetes-Induced Oxidative Stress
Chung, S. S. M., Ho, E. C. M., Lam, K. S. L., & Chung, S. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077408.15865.06 · Cited by 609
Pathogenetic Mechanisms of Diabetic Nephropathy
Schena, F. P., & Gesualdo, L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110970 · Cited by 589
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Self-citationReactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy
Lee, H. B., Yu, M.-R., Yang, Y., Jiang, Z., & Ha, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077410.66390.0f · Cited by 468
Histopathology of Diabetic Nephropathy
Fioretto, P., & Mauer, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.012 · Cited by 467
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Gill, P. S., & Wilcox, C. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1597 · Cited by 457
Maassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s103 · Cited by 439
Inoguchi, T., Sonta, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonoda, N., Sato, N., Sekiguchi, N., Kobayashi, K., Sumimoto, H., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077407.90309.65 · Cited by 435
Murphy, M., Godson, C., Cannon, S., Kato, S., Mackenzie, H. S., Martin, F., & Brady, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5830 · Cited by 385
AGE, RAGE, and ROS in Diabetic Nephropathy
Tan, A. L. Y., Forbes, J. M., & Cooper, M. E. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.006 · Cited by 368
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2570 · Cited by 345
Advanced glycation end-products and the progress of diabetic vascular complications.
Jakuš, V, & Rietbrock, N. (2004) · Physiological Research · doi:10.33549/physiolres.930430 · Cited by 341
Pacher, P., Obrosova, I., Mabley, J., & Szabo, C. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363207 · Cited by 330
The Role of Macrophages in Diabetic Glomerulosclerosis
Furuta, T., Saito, T., Ootaka, T., Soma, J., Obara, K., Abe, K., & Yoshinaga, K. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80393-3 · Cited by 320
Durvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Djordjević, V. B. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)37002-6 · Cited by 293
Wolf, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001846 · Cited by 292
ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy
Li, J.-M., & Shah, A. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077406.67663.e7 · Cited by 288
Effects of Antioxidants in Diabetes-Induced Oxidative Stress in the Glomeruli of Diabetic Rats
Koya, D., Hayashi, K., Kitada, M., Kashiwagi, A., Kikkawa, R., & Haneda, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077412.07578.44 · Cited by 279
Angiotensin-Converting Enzyme II in the Heart and the Kidney
Danilczyk, U., & Penninger, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000205761.22353.5f · Cited by 269
Danesh, F. R., Sadeghi, M. M., Amro, N., Philips, C., Zeng, L., Lin, S., Sahai, A., & Kanwar, Y. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122228799 · Cited by 233
Self-citationMicroalbuminuria and hypertension with focus on type 1 and type 2 diabetes*
Mogensen, C. E. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01157.x · Cited by 227
Pieper, G. M. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199701000-00002 · Cited by 224
Vidotti, D. B., Casarini, D. E., Cristovam, P. C., Leite, C. A., Schor, N., & Boim, M. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2003 · Cited by 224
Vásquez-Vivar, J., Kalyanaraman, B., & Martásek, P. (2003) · Free Radical Research · doi:10.1080/1071576021000040655 · Cited by 218
Mechanisms of Diabetic Nephropathy: Role of Hypertension
Giunti, S., Barit, D., & Cooper, M. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000240331.32352.0c · Cited by 179
Mitochondrial Oxidative Stress and Mitochondrial DNA
Kang, D., & Hamasaki, N. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.195 · Cited by 162
Craven, P. A., Melhem, M. F., Phillips, S. L., & DeRubertis, F. R. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2114 · Cited by 158
Thallas‐Bonke, V., Lindschau, C., Rizkalla, B., Bach, L. A., Boner, G., Meier, M., Haller, H. G., Cooper, M. E., & Forbes, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2921 · Cited by 151
Mechanism of Increased Angiotensin II Levels in Glomerular Mesangial Cells Cultured in High Glucose
Singh, R., Singh, A. K., Alavi, N., & Leehey, D. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060804.40201.6e · Cited by 149
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase
DeRubertis, F. R., Craven, P. A., Melhem, M. F., & Salah, E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.762 · Cited by 143
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 136
Gruden, G., Zonca, S., Hayward, A. E., Thomas, S., Maestrini, S., Gnudi, L., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.4.655 · Cited by 127
GTPases and reactive oxygen species: switches for killing and signaling
Werner, E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00937 · Cited by 115
Smad proteins and transforming growth factor-β signaling
Schiffer, M., von Gersdorff, G., Bitzer, M., Suszták, K., & Böttinger, E. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07708.x · Cited by 115
Gruden, G., Setti, G., Hayward, A. E., Sugden, D., Duggan, S., Burt, D. J., Buckingham, R. E., Gnudi, L., & Viberti, G. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030251 · Cited by 90
Gnudi, L., Viberti, G., Raij, L. R., Rodriguez, V., Burt, D. J., Cortés, P., Hartley, B., Thomas, S., Maestrini, S., & Gruden, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000075949.19968.ef · Cited by 86
The Lack of Cyclin Kinase Inhibitor p27Kip1 Ameliorates Progression of Diabetic Nephropathy
Awazu, M., Omori, S., Ishikura, K., Hida, M., & Fujita, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051726.41601.c0 · Cited by 85
The role of renal proximal tubular cells in diabetic nephropathy
Phillips, A. O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0013-1 · Cited by 76
Modulation of renal-specific oxidoreductase/ myo -inositol oxygenase by high-glucose ambience
Nayak, B., Xie, P., Akagi, S., Yang, Q., Sun, L., Wada, J., Thakur, A., Danesh, F. R., Chugh, S. S., & Kanwar, Y. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509089102 · Cited by 62
Self-citationGlucose transporters in diabetic nephropathy
Brosius, F. C., & Heilig, C. W. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1748-x · Cited by 59
Effect of lovastatin on small GTP binding proteins and on TGF-β1 and fibronectin expression
Kim, S. I., Kim, H. J., Han, D. C., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07714.x · Cited by 58
Hypertension and Diabetes: Role of the Renin-Angiotensin System
Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.007 · Cited by 51
Rabeprazole‐induced acute interstitial nephritis
Geevasinga, N., COLEMAN, P. L., & Roger, S. D. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00365.x · Cited by 50
Sharpe, C. C., & Hendry, B. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000048223.05219.e4 · Cited by 44
Gross, M., Dikow, R., & Ritz, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09412.x · Cited by 37
Dag Second Messengers: Molecular Switches and Growth Control
Quest, A. F. G., Ghosh, S., Xie, W. Q., & Bell, R. M. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5325-0_42 · Cited by 24
Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization
Lin, S., Chugh, S. S., Pan, X., Wallner, E. I., Wada, J., & Kanwar, Y. S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00061.x · Cited by 18
Self-citation
Cited by
Poznyak, A., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051835 · Cited by 1,163
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Croze, M. L., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.011 · Cited by 578
Metadata
- Authors
- Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2008-01
- Volume
- 233
- Issue
- 1
- Pages
- 4-11
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2079837239
- Cited by
- 596
- References
- 57
- FWCI
- 27.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.